Broad screening test for sphingolipid-storage diseases

Lancet

Volumn 354, Issue 9182, 1999, Pages 901-905

  Chen, Chii Shiarng ^a   Patterson, Marc C ^a   Wheatley, Christine L ^a   O'Brien, John F ^a   Pagano, Richard E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOSYLCERAMIDE; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOSINE DERIVATIVE;

ARTICLE; CELL LINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FABRY DISEASE; FIBROBLAST; FLUORESCENCE HISTOCHEMISTRY; GM1 GANGLIOSIDOSIS; GM2 GANGLIOSIDOSIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPIDOSIS; LYSOSOME; METACHROMATIC LEUKODYSTROPHY; MUCOLIPIDOSIS; NIEMANN PICK DISEASE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SANDHOFF DISEASE; SCREENING TEST; TAY SACHS DISEASE;

EID: 0033546958     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)10034-X     Document Type: Article

References (22)

1. Meikle P.J., Hopwood J.J., Clague A.E., Carey W.F. Prevalence of lysosomal storage disorders. JAMA. 281:1999;249-254.
2. Gravel R.A., Clarke J.T.R., Kaback M.M., et al. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D.D., eds. Metabolic and molecular basis of inherited disease, 7th edn. New York: McGraw Hill Inc, 1995: 2839-79.
3. Burkhardt J.K., Huttler S., Klein A.et al. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. Eur J Cell Biol. 73:1977;10-18.
4. Martin O.C., Pagano R.E. Internalization and sorting of a fluorescent analog of glucosylceramide to the Golgi apparatus of human skin fibrobasts: utilization of endocytic and non-endocytic transport mechanisms. J Cell Biol. 125:1994;769-781.
5. Chen C.S., Martin O.C., Pagano R.E. Changes in the spectral properties of a plasma membrane lipid analog during the first seconds of endocytosis in living cells. Biophys J. 72:1997;37-50.
6. Koval M., Pagano R.E. Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal or Niemann-Pick, type A fibroblasts. J Cell Biol. 111:1990;429-442.
7. TM-Sphingolipid analogs to study lipid traffic and metabolism in cells. Methods Enzymol. 1999;. in press.
8. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-917.
9. Koval M., Pagano R.E. Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts. J Cell Biol. 108:1989;2169-2181.
10. Lipsky N.G., Pagano R.E. A vital stain for the Golgi apparatus. Science. 228:1985;745-747.
11. Pagano R.E., Martin O.C., Kang H.C.et al. A novel fluorescent ceramide analog for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J Cell Biol. 113:1991;1267-1279.
12. Pentchev P.G., Vanier M.T., Suzuki K., et al. Niemann-Pick disease type C: a cellular cholesterol lipidosis. In: Scriver C.R., Beaudet A.L., Sly W.S., et al. Metabolic and molecular basis of inherited disease, 7th edn. New York: McGraw Hill, Inc, 1995: 2625-39.
13. Bach G., Zeigler M., Kohn G.et al. Mucopolysaccharide accumulation in cultured skin fibroblasts derived from patients with mucolipidosis IV. Am J Hum Genet. 29:1977;610-618.
14. Chen C.S., Bach G., Pagano R.E. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci USA. 95:1998;6373-6378.
15. Altman D.G., Bland J.M. Diagnostic tests 2: predictive values. BMJ. 309:1994;102.
16. Kobayashi T., Stang E., Fang K.S.et al. A lipid associated with antiphospholipid syndrome regulates endosome structure and function. Nature. 392:1998;193-197.
17. Mukherjee S., Soe T.T., Maxfield F.R. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J Cell Biol. 144:1999;1271-1284.
18. Agmon V., Monti E., Dagan A.et al. Fluorescence-based diagnosis of lipid storage diseases by analysis of the culture medium of skin fibroblasts. Clini Chim Acta. 218:1993;139-147.
19. Galjaard H. Genetic metabolic diseases - early diagnosis and prenatal analysis. 1980;Elsevier, New York.
20. Meikle P.J., Brooks D.A., Ravenscroft E.M.et al. Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin Chem. 43:1997;1325-1335.
21. Hua C.T., Hopwood J.J., Carlsson S.R.et al. Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders. Clin Chem. 44:1998;2094-2102.
22. Kopitz J., Harzer K., Kohlschütter A.et al. Methylamine accumulation in cultured cells as a measure of the aqueous storage compartment in the laboratory diagnosis of genetic lysosomal diseases. Am J Med Genet. 63:1996;198-202.